Daily Headlinez Top News Updates
It begins with an Instagram reel: an influencer touting the most potent weight-loss peptides. Two taps, and the feed is flooded with peptide-fuelled weight-loss journeys. Then the descent into rabbit hole begins: YouTube explainers, AIsimplified scientific papers, Reddit thread obsessions, private chat groups. It ends with a shipment from China of powdered weight-loss medication, unapproved,…
NEW DELHI: The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs – popularly sold under brand names Ozempic, Wegovy and Mounjaro – through advertisements or “disease awareness” campaigns that indirectly encourage their use among the public.In an advisory, Central Drugs Standard Control Organisation said it had come to its notice that some…
On most evenings at a diabetes clinic, the conversation eventually circles back to the same word: cost. Not calories, not carb counts, cost. For many patients, medicines like Ozempic have hovered in that uncomfortable space between medical breakthrough and financial capacity. Doctors spoke of their benefits with measured optimism; patients listened, did the math, and…
NEW DELHI: Weight-loss therapy drug Eli Lilly’s Mounjaro has become the top selling brand in the domestic pharma retail market with sales of nearly Rs 100 crore in Oct, indicating the huge popularity of such treatments across India. Mounjaro has overtaken GSK’s widely prescribed antibiotic and long-established market leader, Augmentin, which totalled sales of Rs…
Eli Lilly and Cipla announced an agreement to distribute and promote tirzepatide in India under a second brand name, Yurpeak. This strategic agreement aims to expand the availability of tirzepatide by enabling broader access across the country beyond cities where Lilly already has an established presence. In March, Lilly launched its blockbuster weight-loss therapy, tirzepatide…
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma market’s long standing market leader GlaxoSmithKline’s Augmentin, an antibiotic. During September, Mounjaro recorded sales of Rs 80 crore, becoming the second-largest brand in the pharma retail market, latest data culled by TOI from market research firm Pharmatrac…
